Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer

Human Molecular Genetics

Volumn 14, Issue 16, 2005, Pages 2349-2356

  Lesueur, Fabienne ^a,c   Pharoah, Paul D ^a   Laing, Stewart ^a   Ahmed, Shahana ^a   Jordan, Clare ^a   Smith, Paula L ^a   Luben, Robert ^b   Wareham, Nicholas J ^b   Easton, Douglas F ^a   Dunning, Alison M ^a   Ponder, Bruce A J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR J; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; NONHUMAN; NORFOLK ISLAND; NUCLEOTIDE SEQUENCE; PENETRANCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTECTION; RISK ASSESSMENT; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

AGED; ALLELES; ANIMALS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LOSS OF HETEROZYGOSITY; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 26444460889     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi237     Document Type: Article

References (27)

1. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark and Finland. [i#N Engl. J Med.#1i] [b#343#1b], 78-85.
2. Antoniou, A.C., Pharoah, P.D.P., McMullen, G., Day, N.E., Stratton, M.R., Peto, J., Ponder, B.A.J. and Easton, D.F. (2002) A comprehensive model for familial breast cancer incorporating [i#BRCA1, BRCA2#1i] and other genes. [i#Br. J. Cancer#1i], [b#86#1b], 76-83.
3. Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C., Borenstein, N. and Dove, W. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. [i#Cell#1i], [b#75#1b], 631-639.
4. Ruivenkamp, C.A., van Wezel, T., Zanon, C., Stassen, A.P., Vlcek, C., Csikos, T., Mons, A.M., Tripodis, N., Perrakis, A., Boerrigter, L. [i#et al.#1i] (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. [i#Nat. Genet.#1i], [b#31#1b], 295-300.
5. Ewart-Toland, A., Briassouli, P., de Koning, J.P., Mao, J.H., Yuan, J., Chan, F., MacCarthy-Morrogh, L., Ponder, B.A., Nagase, H., Burn, J. [i#et al.#1i] (2003) Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. [i#Nat. Genet.#1i], [b#34#1b], 403-412.
6. Demant, P. (2003) Cancer susceptibility in the mouse: Genetics, biology and implications for human cancer. [i#Nat. Rev. Genet.#1i], [b#4#1b], 721-734.
7. Keane, M.M., Lowrey, G.A., Ettenberg, S.A., Dayton, M.A. and Lipkowitz, S. (1996) The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. [i#Cancer Res.#1i], [b#56#1b], 4236-4243.
8. Jallal, B., Mossie, K., Vasiloudis, G., Knyazev, P., Zachwieja, J., Clairvoyant, F., Schilling, J. and Ullrich, A. (1997) The receptor-like protein-tyrosine phosphatase DEP-1 is constitutively associated with a 64-kDa protein serine/threonine kinase. [i#J. Biol. Chem.#1i], [b#272#1b], 12158-12163.
9. Trapasso, F., Iuliano, R., Boccia, A., Stella, A., Visconti, R., Bruni, P., Baldassarre, G., Santoro, M., Viglietto, G. and Fusco, A. (2000) Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). [i#Mol. Cell. Biol.#1i], [b#20#1b], 9236-9246.
10. Ruivenkamp, C., Hermsen, M., Postma, C., Klous, A., Baak, J., Meijer, G. and Demant, P. (2003) LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. [i#Oncogene#1i], [b#22#1b] 3472-3474.
11. Carlson, C.S., Eberle, M.A., Rieder, M.J., Yi, Q., Kruglyak, L. and Nickerson, D.A. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. [i#Am. J. Hum. Genet.#1i], [b#74#1b], 106-120.
12. Stram, D.O. (2004) Tag SNP selection for association studies. [i#Genet. Epidemiol.#1i], [b#27#1b], 365-374.
13. Goode, E.L., Pharoah, P.D.P., Wareham, N. and Easton, D.F. (2005) No evidence for population substructure within the EPIC-Norfolk cohort. [i#96th Annual Meeting of the American Association of Cancer Research#1i]. Annaheim, California.
14. Cardon, L.R. and Palmer, L.J. (2003) Population stratification and spurious allelic association. [i#Lancet#1i], [b#361#1b], 598-604.
15. Tomlinson, I.P., Beck, N.E., Neale, K. and Bodmer, W.F. (1996) Variants at the secretory phospholipase A2 (PLA2G2A) locus: Analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours. [i#Ann. Hum. Genet.#1i], [b#60#1b], 369-376.
16. Tomlinson, I.P., Neale, K., Talbot, I.C., Spigelman, A.D., Williams, C.B., Phillips, R.K. and Bodmer, W.F. (1996) A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. [i#J. Med. Genet.#1i], [b#33#1b], 268-273.
17. Manenti, G., Gariboldi, M., Fiorino, A., Zanesi, N., Pierotti, M.A. and Dragani, T.A. (1997) Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. [i#Cancer Res.#1i] [b#57#1b], 4164-4166.
18. Manenti, G., De Gregorio, L., Pilotti, S., Falvella, F.S., Incarbone, M., Ravagnani, F., Pierotti, M.A. and Dragani, T.A. (1997) Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. [i#Carcinogenesis#1i], [b#18#1b], 1917-1920.
19. Dragani, T.A., Hirohashi, S., Juji, T., Kawajiri, K., Kihara, M., Ono-Kihara, M., Manenti, G., Nomoto, T., Sugimura, H., Genka, K. [i#et al.#1i] (2000) Population-based mapping of pulmonary adenoma susceptibility 1 locus. [i#Cancer Res.#1i], [b#60#1b], 5017-5020.
20. Yanagitani, N., Kohno, T., Sunaga, N., Kunitoh, H., Tamura, T., Tsuchiya, S., Saito, R. and Yokota, J. (2002) Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1. [i#Carcinogenesis#1i], [b#23#1b], 1177-1183.
21. Egan, K.M., Newcomb, P.A., Ambrosone, C.B., Trentham-Dietz, A., Titus-Ernstoff, L., Hampton, J.M., Kimura, M. and Nagase, H. (2004) STK15 polymorphism and breast cancer risk in a population-based study. [i#Carcinogenesis#1i], [b#25#1b], 2149-2153.
22. DiCioccio, R., Song, H., Waterfall, C., Kimura, M., Nagase, H., McGuire, V., Hogdall, E., Shah, M.N., Luben, R.N., Easton, D.F. [i#et al.#1i] (2004) [i#STK15#1i] polymorphisms and association with risk of invasive ovarian cancer. [i#Cancer Epidemiol. Biomarkers Prev.#1i], [b#13#1b], 1589-1594.
23. Dragani, T.A. (2003) 10 years of mouse cancer modifier loci: Human relevance. [i#Cancer Res.#1i], [b#63#1b], 3011-3018.
24. Day, N., Oakes, S., Luben, R., Khaw, K.T., Bingham, S., Welch, A. and Wareham, N. (1999) EPIC-Norfolk: Study design and characteristics of the cohort. European Prospective Investigation of Cancer. [i#Br. J. Cancer#1i] [b#80#1b](Suppl. 1), 95-103.
25. The International HapMap Project. (2003) [i#Nature#1i], [b#426#1b], 789-796.
26. Barrett, J.C., Fry, B., Mallet, J. and Daly, M.J., (2005) Haploview: analysis and visualization of LD and haplotype maps. [i#Bioinformatics#1i] [b#21#1b], 263-265.
27. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. and Poland, G.A., (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. [i#Am. J. Hum. Genet.#1i], [b#70#1b], 425-434.